Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial
根据 HER2 扩增程度评估接受辅助化疗（伴或不伴 1 年曲妥珠单抗治疗）患者的无病生存期：HERA 试验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2008.19.7939
Dowsett, Mitch; Procter, Marion; McCaskill-Stevens, Worta; de Azambuja, Evandro; Dafni, Urania; Rueschoff, Josef; Jordan, Bruce; Dolci, Stella; Abramovitz, Mark; Stoss, Oliver; Viale, Giuseppe; Gelber, Richard D; Piccart-Gebhart, Martine; Leyland-Jones, Brian
